Caribou Biosciences, Inc.

CRBU Nasdaq CIK: 0001619856

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
Mailing Address 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
Phone 510-982-6030
Fiscal Year End 1231
EIN 453728228

Financial Overview

FY2025

$368.40M
Stockholders' Equity
$-1.59
EPS

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events March 31, 2026 View on SEC
10-K Annual financial report March 5, 2026 View on SEC
8-K Current report of material events March 5, 2026 View on SEC
4 Insider stock transaction report February 27, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 20, 2026 View on SEC
4 Insider stock transaction report February 20, 2026 View on SEC

Annual Reports

10-K March 5, 2026
  • Proprietary chRDNA gene-editing technology offers enhanced precision for 'off-the-shelf' cell therapies targeting cancer.
  • Strategic restructuring in 2025 focuses resources on the most promising clinical and preclinical programs.
View Analysis

Insider Trading

SELL 4 insiders 5 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.